Doctors' Use of Drug Database Increases Amid Opioid Fight
State officials said that more than 92,000 health care providers had registered to use an electronic database that tracks patients who are prescribed controlled substances.
September 24, 2018 at 12:25 PM
3 minute read
|
One of Florida's main weapons to thwart “doctor shopping” has been expanding substantially after the passage of a tough new law aimed at addressing the continuing opioid crisis.
State officials said Thursday that more than 92,000 health care providers had registered to use an electronic database that tracks patients who are prescribed controlled substances.
The August total is more than double the number of providers who were registered to use the system the previous year.
Bruce Culpepper, a consultant for the Florida Department of Health, told members of the Health Information Exchange Coordinating Committee about the “major uptick in activity” in response to the new law, which, for the first time, requires doctors to consult the database before writing prescriptions.
The providers made 4.75 million inquiries into the database during August, said Culpepper, who coordinates the department's health-information exchange activities.
Moreover, Culpepper said Florida has been working with neighboring Alabama and Georgia, as well as Kentucky, on integrating Florida's prescription drug database with their programs.
The Florida Legislature gave the green light to the monitoring program in 2009. The state required pharmacists to enter information about most controlled substances the following year when the database became operational.
But it wasn't until this year that lawmakers also required doctors to use the database to ensure that patients weren't “doctor shopping,” or seeking prescriptions for addictive drugs from multiple physicians.
The mandate that they check the system before prescribing was one of many changes lawmakers approved to try to abate the opioid crisis.
The Legislature also banned doctors from writing prescriptions for more than three-day supplies of controlled substances. In medically necessary instances, physicians can write prescriptions for seven-day supplies. The new restrictions don't apply to cancer patients, people who are terminally ill, palliative care patients and those who suffer from major trauma.
Before the mandate, just 20.6 percent of the 73,085 licensed medical doctors in the state were registered to use the prescription-drug monitoring program, according to a December 2017 annual report. The medical doctors, however, accounted for nearly one-third of the 35.8 million queries that were made to the database.
Jeff Scott, general counsel of the Florida Medical Association, said doctors initially were confused by the new mandate and whether it applied to them. Scott, who has been with the FMA for 21 years, said it's been one of the more controversial laws the Legislature has passed in his experience with the statewide physician group.
“We were getting quite a bit of questions about it prior to it going into effect,” he said, adding that the FMA's offices were fielding as many as 30 phone calls a day over the summer before the law took effect July 1.
Legislators acted this year to address the growing opioid problem. In 2016, for example, fentanyl caused 1,390 deaths, heroin caused 952 deaths, oxycodone caused 723 deaths, and hydrocodone caused 245 deaths, according to a House staff analysis.
Meanwhile, U.S. Surgeon General Jerome Adams on Thursday released a report that said, based on preliminary data, opioid overdoses were responsible for killing 131 Americans daily last year. In 2016, more than 115 Americans died daily from opioid overdoses.
Christine Sexton reports for the News Service of Florida.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
You Might Like
View AllFla.'s Statute of Limitations and Statutes of Repose in Med Mal Cases: It's Not Over Until It's Over
6 minute readGC of Florida State Agency Steps Down After Threatening TV Stations That Aired Abortion-Rights Ad
Trending Stories
- 1Gibson Dunn Sued By Crypto Client After Lateral Hire Causes Conflict of Interest
- 2Trump's Solicitor General Expected to 'Flip' Prelogar's Positions at Supreme Court
- 3Pharmacy Lawyers See Promise in NY Regulator's Curbs on PBM Industry
- 4Outgoing USPTO Director Kathi Vidal: ‘We All Want the Country to Be in a Better Place’
- 5Supreme Court Will Review Constitutionality Of FCC's Universal Service Fund
Who Got The Work
Michael G. Bongiorno, Andrew Scott Dulberg and Elizabeth E. Driscoll from Wilmer Cutler Pickering Hale and Dorr have stepped in to represent Symbotic Inc., an A.I.-enabled technology platform that focuses on increasing supply chain efficiency, and other defendants in a pending shareholder derivative lawsuit. The case, filed Oct. 2 in Massachusetts District Court by the Brown Law Firm on behalf of Stephen Austen, accuses certain officers and directors of misleading investors in regard to Symbotic's potential for margin growth by failing to disclose that the company was not equipped to timely deploy its systems or manage expenses through project delays. The case, assigned to U.S. District Judge Nathaniel M. Gorton, is 1:24-cv-12522, Austen v. Cohen et al.
Who Got The Work
Edmund Polubinski and Marie Killmond of Davis Polk & Wardwell have entered appearances for data platform software development company MongoDB and other defendants in a pending shareholder derivative lawsuit. The action, filed Oct. 7 in New York Southern District Court by the Brown Law Firm, accuses the company's directors and/or officers of falsely expressing confidence in the company’s restructuring of its sales incentive plan and downplaying the severity of decreases in its upfront commitments. The case is 1:24-cv-07594, Roy v. Ittycheria et al.
Who Got The Work
Amy O. Bruchs and Kurt F. Ellison of Michael Best & Friedrich have entered appearances for Epic Systems Corp. in a pending employment discrimination lawsuit. The suit was filed Sept. 7 in Wisconsin Western District Court by Levine Eisberner LLC and Siri & Glimstad on behalf of a project manager who claims that he was wrongfully terminated after applying for a religious exemption to the defendant's COVID-19 vaccine mandate. The case, assigned to U.S. Magistrate Judge Anita Marie Boor, is 3:24-cv-00630, Secker, Nathan v. Epic Systems Corporation.
Who Got The Work
David X. Sullivan, Thomas J. Finn and Gregory A. Hall from McCarter & English have entered appearances for Sunrun Installation Services in a pending civil rights lawsuit. The complaint was filed Sept. 4 in Connecticut District Court by attorney Robert M. Berke on behalf of former employee George Edward Steins, who was arrested and charged with employing an unregistered home improvement salesperson. The complaint alleges that had Sunrun informed the Connecticut Department of Consumer Protection that the plaintiff's employment had ended in 2017 and that he no longer held Sunrun's home improvement contractor license, he would not have been hit with charges, which were dismissed in May 2024. The case, assigned to U.S. District Judge Jeffrey A. Meyer, is 3:24-cv-01423, Steins v. Sunrun, Inc. et al.
Who Got The Work
Greenberg Traurig shareholder Joshua L. Raskin has entered an appearance for boohoo.com UK Ltd. in a pending patent infringement lawsuit. The suit, filed Sept. 3 in Texas Eastern District Court by Rozier Hardt McDonough on behalf of Alto Dynamics, asserts five patents related to an online shopping platform. The case, assigned to U.S. District Judge Rodney Gilstrap, is 2:24-cv-00719, Alto Dynamics, LLC v. boohoo.com UK Limited.
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250